When emergency medical teams respond to an overdose call, their most reliable tool has long been naloxone — a medication that rapidly reverses the effects of opioids and has saved hundreds of thousands of lives since the fentanyl crisis began. That tool is now losing its effectiveness against a new and rapidly spreading threat. A veterinary sedative known on the street as "rhino tranq" — scientifically called medetomidine — is increasingly being mixed into the illegal fentanyl supply, and unlike fentanyl, it does not respond to naloxone.
On April 2, 2026, the Centers for Disease Control and Prevention (CDC) and the White House Office of National Drug Control Policy (ONDCP) issued a joint Health Advisory warning clinicians, public health professionals, and the public about the escalating presence of medetomidine in illicit drug samples across the United States. The advisory represents one of the most significant updates to the overdose crisis landscape in years — and its implications for cities like Chicago, Philadelphia, and New York are deeply alarming.
